RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER

被引：77
|
作者：
CAVALLI, F
GOLDHIRSCH, A
JUNGI, F
MARTZ, G
MERMILLOD, B
ALBERTO, P
机构：
[1] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND
[2] INSELSPITAL,LUDWIG INST CANC RES,CH-3010 BERN,SWITZERLAND
[3] KANTONSSPITAL,MED KLIN C,DIV ONCOL,CH-9006 ST GALLEN,SWITZERLAND
[4] UNIV HOSP ZURICH,DIV ONCOL,CH-8091 ZURICH,SWITZERLAND
[5] HOP CANTONAL,SWISS GRP CLIN CANC RES,STAT OFF,CH-1211 GENEVA 4,SWITZERLAND
[6] HOP CANTONAL,DIV ONCOL,CH-1211 GENEVA 4,SWITZERLAND
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 05期
关键词：
D O I：
10.1200/JCO.1984.2.5.414
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：414 / 419
页数：6
相关论文
共 50 条
  • [31] HIGH-DOSE MEDROXYPROGESTERONE ACETATE PLUS MITOMYCIN-C OR VINDESINE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FALKSON, CI
    FALKSON, HC
    FALKSON, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (04): : 431 - 434
  • [32] HIGH-DOSE MEGESTROL-ACETATE FOR THE TREATMENT OF ADVANCED BREAST-CANCER - DOSE AND TOXICITIES
    AISNER, J
    TCHEKMEDYIAN, NS
    MOODY, M
    TAIT, N
    SEMINARS IN HEMATOLOGY, 1987, 24 (02) : 48 - 55
  • [33] THE PHARMACOKINETICS OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE THERAPY OF METASTATIC BREAST-CANCER
    BLOSSEY, HC
    BARTSCH, HH
    KOEBBERLING, J
    NAGEL, GA
    ACTA ENDOCRINOLOGICA, 1981, 97 : 207 - 207
  • [34] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR THE TREATMENT OF METASTATIC BREAST-CANCER WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE
    BLOSSEY, HC
    WANDER, HE
    KOEBBERLING, J
    NAGEL, GA
    CANCER, 1984, 54 (06) : 1208 - 1215
  • [35] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    TCHEKMEDYIAN, NS
    TAIT, N
    ABRAMS, J
    AISNER, J
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 44 - 49
  • [36] HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS OOPHORECTOMY AS 1ST-LINE THERAPY OF ADVANCED BREAST-CANCER IN PREMENOPAUSAL PATIENTS
    MARTONI, A
    LONGHI, A
    CANOVA, N
    PANNUTI, F
    ONCOLOGY, 1991, 48 (01) : 1 - 6
  • [37] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) FOR THE TREATMENT OF METASTATIC BREAST-CANCER (MBC)
    HORTOBAGYI, G
    FRYE, D
    BUZDAR, A
    YAP, HY
    SCHELL, F
    BLUMENSCHEIN, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 148 - 148
  • [38] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE IN HEAVILY PRETREATED PATIENTS WITH METASTATIC BREAST-CANCER
    GOSS, PE
    ASHLEY, S
    POWLES, TJ
    COOMBES, RC
    CANCER TREATMENT REPORTS, 1986, 70 (06): : 777 - 779
  • [39] ORAL HIGH-DOSE MEDROXYPROGESTERONE ACETATE CAUSES ADRENAL SUPPRESSION IN PATIENTS WITH BREAST-CANCER
    VANVEELEN, H
    HOUWERZIJL, J
    RODING, TJ
    TJABBES, T
    VERMEER, RJI
    SLEIJFER, DT
    PRATT, JJ
    WILLEMSE, PHB
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (10): : 1035 - 1036
  • [40] STEROID-HORMONE RECEPTORS AND RESPONSE TO HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED BREAST-CANCER
    NOMURA, Y
    TASHIRO, H
    HISAMATSU, K
    SHINOZUKA, K
    ANTICANCER RESEARCH, 1988, 8 (04) : 647 - 652
12345